Open AccessBalancing RAF, MEK, and EGFR Inhibitor Doses to Achieve Clinical Responses and Modulate Toxicity in BRAF V600E Colorectal Cancer
Author(s) -
Sebastián Mondaca,
Mario E. Lacouture,
Jonathan Hersch,
Rona Yaeger
Publication year - 2018
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.18.00088
Subject(s) - colorectal cancer , toxicity , egfr inhibitors , medicine , mek inhibitor , pharmacology , cancer research , cancer , epidermal growth factor receptor , chemistry , mapk/erk pathway , phosphorylation , biochemistry